Evidence map›Paper›PMID 36062252›Full record

ReviewSubstance abuse : research and treatment2022

Barriers and Facilitators to Substance Use Disorder Treatment: An Overview of Systematic Reviews.

Ali Farhoudian, Emran Razaghi, Zahra Hooshyari, Alireza Noroozi, Azam Pilevari, Azarakhsh Mokri, Mohammad Reza Mohammadi, Mohsen Malekinejad

Registry-linked trialAbstract readReview
In one paragraph

Review in Substance abuse : research and treatment, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07121296 (Screen, Treat and Retain People With Primary Meth Use Disorder at MMT Clinics), which is not on this map. Cited by 98 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07121296 naactive not recruitingnot on this mapstarted 2025, after this paper: background citation

Screen, Treat and Retain People With Primary Meth Use Disorder at MMT Clinics

TypeinterventionalSponsorHanoi Medical UniversityRan2025 to 2025Enrolled60ConditionsMethamphetamine Use DisorderArmsContingency management for substance use, Contingency management for attendance, Group-based Matrix counseling, Individual-based Matrix counseling
3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. A qualitative exploration of women's experiences, stigma, and access to care in gaming disorder.European psychiatry : the journal of the Association of European Psychiatrists · 2026
    Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ali FarhoudianDepartment of Psychiatry, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Emran RazaghiDepartment of Psychiatry, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Zahra HooshyariDepartment of Geriatric Medicine, Ziaeian Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
Alireza NorooziIranian National Center for Addiction Studies (INCAS), Tehran University of Medical Science, Tehran, Iran.
Azam PilevariDepartment of Sociology, Kharazmi University, Karaj, Iran.
Azarakhsh MokriDepartment of Psychiatry, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad Reza MohammadiDepartment of Psychiatry, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Mohsen MalekinejadDepartment of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objective: This investigation explored the barriers and facilitators to substance use disorder (SUD) treatment in the integrated paradigm. methods: A search technique for barriers and facilitators of SUD treatment was applied to the PubMed and Web of Science databases to identify relevant systematic reviews. The eligibility criteria included systematic review (SR) or SR plus meta-analysis (MA) articles published before the end of 2021, human research, and the English language. Each of the 12 relevant review articles met the inclusion criteria. AMSTAR was utilised to evaluate the methodological quality of the systematic reviews. results: Two authors analysed 12 SR/SR-MA articles to identify barriers or facilitators of SUD treatment. The cumulative summary results of these 12 evaluations revealed that barriers and facilitators may be classified into 3 levels: individual, social and structural. By analysing these review papers, 37 structural barriers, 21 individual barriers and 19 social barriers were uncovered, along with 15 structural facilitators, 9 social facilitators and 3 individual facilitators. conclusions: The majority of barriers indicated in the review articles included in this analysis are structural, as are the majority of facilitators. Consequently, the design of macro models for the treatment of substance use disorders may yield various outcomes and potentially affect society and individual levels.

Indexed as

Barrierfacilitatorreviewsubstance use disordertreatment

Identifiers

PMID36062252
PMCPMC9434658

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.